Upcoming catalysts, page-157

Experian Group have a 99% Success rate. They would not have advised Resapp to lodge if they didn't believe they could achieve FDA, if you remember early in the year why it took so long to submit, that was because Experian Group were making sure everything was good to go, going over it with a fine tooth comb.

Resapp has already shown that it is a safe product through receiving CE Mark Clearance. TICK

FDA will ask if the product is effective in doing what it says it does.
In Tony's words "It's a renounding yes"
The Doctors could only agree 66% of the time if you remember in the conference call. We are scoring above 70% TICK
Remember they need the same or higher

FDA will also ask is there a need for the product, doctors from telehealth platforms are diagnosing patients as we speak will no proper diagnostic tools for respiratory illness. So another TICK